Navigation Links
Lexicon to Provide First Quarter 2012 Financial Results
Date:4/25/2012

THE WOODLANDS, Texas, April 25, 2012 /PRNewswire/ -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), announced today that it will release its first quarter 2012 financial results on Thursday, May 3, 2012 before the financial markets open.  Lexicon management will hold a conference call and webcast to discuss financial results for the quarter and program status at 11:00 a.m. Eastern Time that same day.

The dial-in number for the conference call is 888-645-5785 (within the US/Canada) or 970-300-1531 (international).  The conference ID for all callers is 73722762.  Investors can access a live webcast of the call at www.lexpharma.com.  An archived version of the webcast will be available on Lexicon's corporate website at www.lexpharma.com through May 31, 2012.

About Lexicon
Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has four drug programs in mid-stage development for diabetes, irritable bowel syndrome, carcinoid syndrome and rheumatoid arthritis, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement
This press release contains "forward-looking" statements, including statements relating to Lexicon's growth and future operating results, discovery and development of products, strategic alliances a
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Lexicon Pharmaceuticals to Present at the Cowen and Company 32nd Annual Health Care Conference
2. Lexicon Pharmaceuticals to Present at the RBC Healthcare Conference
3. Lexicon to Report Fourth Quarter and Year End 2011 Financial Results on February 22, 2012
4. Lexicon Pharmaceuticals to Present at the 30th Annual J.P. Morgan Healthcare Conference
5. Lexicon Announces Commencement of Rights Offering to Stockholders
6. Lexicon to Present LX4211 Clinical and Preclinical Data at Diabetes Conference
7. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2011 Third Quarter Results
8. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2011 Financial Results
9. Lexicon Presents LX4211 Clinical Data at European Association for the Study of Diabetes Annual Meeting
10. Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
11. Lexicon Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... , July 31, 2015  Physicians and payers ... the biopharmaceutical market. Patients are better informed and ... and switching therapies. This shift in power is ... efforts toward patient-focused marketing. As part ... have learned it,s important to educate, communicate and ...
(Date:7/31/2015)... -- Seeger Weiss LLP is reporting that on July 13, 2015, ... C.R. Bard, the manufacturer of Inferior vena cava (IVC) ... the agency found at two of Bard,s facilities. Bard was ... them during Inspectional Observations that occurred on November 18, 2014, ... , location and on October 6, 2014, through November ...
(Date:7/31/2015)... 2015 Today, the National Association of ... issued a report urging greater accountability by the ... against websites illegally selling medications online. As detailed ... Program Progress Report for State and Federal Regulators: ... websites illegally distribute medications and avoid retribution. Such ...
Breaking Medicine Technology:Consumers Forcing Pharmaceutical Industry to Shift its Marketing Focus from Products to Patients 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 2Seeger Weiss LLP Reports That The FDA Has Issued A Warning Letter To IVC Filter Manufacturer, C.R. Bard 3NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 2NABP Stresses Need for Accountability in Enforcing Internet Policies to Protect the Public From Illegal Online Drug Sellers 3
... June 8, 2011 ForteBio®, Inc., a leading ... of biotherapeutic and pharmaceutical products, today announced the ... Fc Capture (AMC) biosensor for use on the ... high-throughput rapid kinetic characterization and screening of mouse ...
... 8, 2011 TetraLogic Pharmaceuticals, a biopharmaceutical company developing ... today announced the appointment of Mr. Jonathan B. Lloyd ... president of corporate development. Mr. Lloyd ... development and finance experience.  He has led negotiations, valuation ...
Cached Medicine Technology:ForteBio Introduces New Biosensor for Kinetic Analysis and Screening of Mouse IgG Antibodies 2TetraLogic Appoints Jonathan B. Lloyd Jones as Chief Financial Officer and Vice President Corporate Development 2
(Date:8/3/2015)... ... 2015 , ... Novatus, Inc. today launched the largest and ... as announced the date of its next major release. , Version 6.0 introduces ... as well as enhancements to the customer experience. Users now enjoy a ...
(Date:8/3/2015)... ... 03, 2015 , ... Results of a comprehensive survey by ... and Policy Analysis show widespread support for the U.S. Affordable Care Act among ... agreed that the controversial law passed in 2010 had “more good than bad” ...
(Date:8/3/2015)... ... August 03, 2015 , ... Sensato and ... Secure Healthcare Systems” This three-day, highly interactive and immersive workshop, has been ... access to the tactics, techniques and practices required to design and develop highly ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug Administration (FDA) ... similar to deoxycholic acid, which occurs naturally in the body and helps absorb and ... this area of the body. These are invasive procedures and very expensive for most ...
(Date:8/3/2015)... ... ... A July 13 article from The Daily Mail titled "Jab That ... Can Last 'For Five Weeks'" discusses the use of stem cells to help ... harvesting stem cell-rich bone marrow from the hip, known as bone marrow stromal cells ...
Breaking Medicine News(10 mins):Health News:Novatus Unveils Milestone Software Release 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 2Health News:Survey Finds Support for the Affordable Care Act Among Physician Leaders 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 2Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 3Health News:Sensato and Divurgent are pleased to announce the development of it’s new program “Designing Secure Healthcare Systems” 4Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 2Health News:Los Angeles Spine Surgeon Gives Insight into How Stem Cells Can Relieve Back Pain 3
... is showing great covenant in dental restorative work, ... and Technology at Ohio.//This ACP has new physical-chemical ... OSU. “It’s more soluble than other calcium phosphates ... stable dental mineral hydroxyapatite, which is the main ...
... Getting cold out of doors condenses the blood and increases ... of University of Texas, it has been found that too ... - in Britain. He believes that cold temperatures alter the ... raises the risk of clotting and heart attack. ...
... amino-acid taste receptor.Dr Charles S. Zuker, from the ... California, San Diego, reports his team's findings in ... — bitter, salty, sour, sweet, and umami. Umami ... that responded to umami have been discovered by ...
... hospital who smoke and have a history of alcohol ... almost 400 patients// to find if there was a ... them into four groups:current tobacco use only, history of ... patients with both current tobacco use and past alcohol ...
... suggests that an air pollutant emitted by power plants ... can increase your chances of dying from lung cancer ... air pollution. The study authors contend that simply living ... particulate matter" that makes its way into your lungs ...
... best method for tackling a irksome duo: attention deficit hyperactivity ... suggests that mixing// two of the most commonly prescribed drugs ... struggle with a combination of ADHD and muscular control disorders. ... and 90 percent of children with a tic disorder also ...
Cached Medicine News:Health News:Comprehension of taste receptor, 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: